MAPS continues to be “optimistic about treatment coverage, but not naive for the troubles”. MDMA therapy will require exclusive coverage less than insurance plan, medicare, and medicaid. More information on protection will arrive as we in the vicinity of FDA approval. When will other nations authorize MDMA and on what terms?MAPS will not be sup